Macrogenics (MGNX) Change in Acquisitions & Divestments (2016 - 2026)
Macrogenics (MGNX) reported Change in Acquisitions & Divestments of $47.6 million for Q1 2026, up 159.69% year-over-year from $18.3 million in Q1 2025, and up 106.34% quarter-over-quarter from $23.1 million in Q4 2025.
Macrogenics (MGNX) Change in Acquisitions & Divestments (2016 - 2026) Analysis & Trends
Macrogenics (MGNX) has 11 years of Change in Acquisitions & Divestments data on file, last reported at $47.6 million in Q1 2026.
- Change in Acquisitions & Divestments for Q1 2026 came in at $47.6 million, up 159.69% year-over-year; the trailing twelve-month figure through Mar 2026 was $125.4 million (down 4.7% YoY), and the FY2025 annual result was $96.1 million, down 49.41% from the prior year.
- Change in Acquisitions & Divestments rose to $47.6 million in Q1 2026 per MGNX's latest filing, from $23.1 million in the prior quarter.
- Over five years, Change in Acquisitions & Divestments peaked at $76.8 million in Q1 2024 and troughed at $8.6 million in Q2 2025.
- A 5-year average of $40.6 million and a median of $41.0 million in 2024 frame the typical range for Change in Acquisitions & Divestments.
- The sharpest annual moves came in 2024 and 2025: Change in Acquisitions & Divestments jumped 222.29% in 2024, then sank 84.77% in 2025.
- A 5-year view of Change in Acquisitions & Divestments shows it stood at $39.8 million in 2022, then soared by 55.75% to $61.9 million in 2023, then slumped by 74.36% to $15.9 million in 2024, then jumped by 45.44% to $23.1 million in 2025, then jumped by 106.34% to $47.6 million in 2026.
- Business Quant data shows MGNX's Change in Acquisitions & Divestments at $47.6 million in Q1 2026, $23.1 million in Q4 2025, and $46.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Macrogenics | 260.14 Mn | 193.63 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 47.64 Mn |
| Mar 31, 2026 | 47.64 Mn |
| Dec 31, 2025 | 23.09 Mn |
| Dec 31, 2025 | 23.09 Mn |
| Sep 30, 2025 | 46.12 Mn |
| Sep 30, 2025 | 46.12 Mn |
| Jun 30, 2025 | 8.59 Mn |
| Jun 30, 2025 | 8.59 Mn |
| Mar 31, 2025 | 18.35 Mn |
| Mar 31, 2025 | 18.35 Mn |
| Dec 31, 2024 | 15.88 Mn |
| Dec 31, 2024 | 15.88 Mn |
| Sep 30, 2024 | 41.00 Mn |
| Sep 30, 2024 | 41.00 Mn |
| Jun 30, 2024 | 56.40 Mn |
| Jun 30, 2024 | 56.40 Mn |
| Mar 31, 2024 | 76.75 Mn |
| Mar 31, 2024 | 76.75 Mn |
| Dec 31, 2023 | 61.91 Mn |
| Dec 31, 2023 | 61.91 Mn |